SavedAdd your journal

Journals / Uludağ Üniversitesi Tıp Fakültesi Dergisi / 2002 / Cilt: 28 - Sayı: 3

The serum interleukin 1 alfa levels in patients with rheumatoid arthritis and correlation with insulin resistance

Romatoid artritli hastalarda serum interleukin 1alfa düzeyleri ile insülin direnci arasındaki ilişki

Cihan TOP
Mehmet Emin ÖNDE
Özcan KESKİN
Bekir Yılmaz CİNGÖZBAY
Altuğ TUNCEL
Pages
81–84
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The fasting insulin levels, HOMA scores and serum IL-1 alfa levels were significantly higher in all patients with rheumatoid arthritis than in control subjects (14.7±6.7 vs. 8.7±1.9 µIU/ml, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Insulin resistance is a common pathological state in which target cells fail to respond to ordinary levels of circulating insulin.
📊
Key Findings & Data:The aim of our study was evaluate the correlation of the changes in serum IL-1 alfa levels with glucose metabolism abnormality, such as insulin resistance, in patients with rheumatoid arthritis.
💡
Conclusion & Impact:The fasting insulin levels, HOMA scores and serum IL-1 alfa levels were significantly higher in all patients with rheumatoid arthritis than in control subjects (14.7±6.7 vs. 8.7±1.9 µIU/ml, p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Insulin resistance is a common pathological state in which target cells fail to respond to ordinary levels of circulating insulin. The cytokines are the subject of intense research for potential effects on insulin sensitivity. The aim of our study was evaluate the correlation of the changes in serum IL-1 alfa levels with glucose metabolism abnormality, such as insulin resistance, in patients with rheumatoid arthritis. In this study, 36 subjects (22 women and 14 men, aged 51.5 ±17.1 years, ranging between 21-80, BMI 27.1±5.0 kg/m²) with varying degrees of disease activity and a control group of 20 healthy subjects matched by age, sex, and body mass index were evaluated. The fasting serum IL-1 alfa and insulin levels were measured. HOMA-estimated insulin sensitivity was calculated. The fasting insulin levels, HOMA scores and serum IL-1 alfa levels were significantly higher in all patients with rheumatoid arthritis than in control subjects (14.7±6.7 vs. 8.7±1.9 µIU/ml, p

Özet

Dolaşımdaki normal düzeylerde insüline hedef hücrenin cevabında bozulma olarak tanımlanan insülin direnci, sık rastlanan patolojik bir durumdur. Sitokinlerin insülin duyarlılığı üzerindeki potansiyel etkileri yoğun araştırmalara konu olmuştur. Bu çalışmanın amacı, romatoid artritli hastalarda insülin direnci gibi glukoz metabolizma anormallikleri ile serum interleukin 1. düzeyleri arasındaki bağlantıyı araştırmaktır. Çalışmaya değişik derecelerde hastalık aktivitesine sahip romatoid artritli 36 hasta (22 kadın ve 14 erkek, ortalama yaş: 51.5 ±17.1 yıl (21-80 yaş arası), ortalama VKİ: 27.1±5.0 kg/m²) ve yaş, cinsiyet, VKİ olarak benzer özelliklere sahip 20 sağlıklı kontrol dahil edilmiştir. Açlık serum IL-1 alfa ve insülin düzeyleri ölçüldü. İnsülin duyarlılığı HOMA yöntemiyle hesaplandı. Romatoid artritli hastalarda kontrollere oranla açlık serum insülin düzeyleri, HOMA skorları ve serum IL-1 alfa düzeyleri anlamlı derecede yüksekti (14.7±6.7, 8.7±1.9 µIU/ml, p

🔖

Cite This Article

TOP, C., ÖNDE, M. E., KESKİN, Ö., CİNGÖZBAY, B. Y., TUNCEL, A. (2022). The serum interleukin 1 alfa levels in patients with rheumatoid arthritis and correlation with insulin resistance. Uludağ Üniversitesi Tıp Fakültesi Dergisi, Cilt: 28 - Sayı: 3, 81–84. https://ajindex.com/articles/643802

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Gordon DA, Hastings DE: Rheumatology, second edition. in Klippel JH, Dieppe PA(eds): Rheumatoid arthritis, clinical features of early, progressive and late disease. London, 1998, 5:3.1-3.4s
  2. Matteson EJ, Cohen MD, Conn DL: Rheumatology, second edition. in Klippel JH, Dieppe PA(eds): Rheumatoid arthritis, clinical features and systemic involvment. London, 1998, 5:4.1- 4.8s
  3. Gaston H: Rheumatology, second edition. in Klippel JH, Dieppe PA(eds): Rheumatoid arthritis, cellular immunity in RA. London, 1998, 5:10.1-10.6s
  4. Bresnihan B: Pathogenesis of joint damage in rheumatoid arthritis. J Rheumatol 1999; 26: 717-9
  5. Wooley P: Rheumatology, second edition. in Klippel JH, Dieppe PA(eds): Rheumatoid arthritis, animal model of arthritis. London, 1998, 5:8.1-8.6s
  6. Virkamaki A, Ueki K, Kahn CR: Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 1999; 103: 931-43
  7. Roach P, Zick Y, Formisane P, Accili D, Taylor SI, Gorden P: A novel human IR gene mutation uniquely inhibits insulin binding without impairing posttranslational processing. Diabetes 43: 1096-1102, 1994
  8. Arnett FC, Edworthy SM, Bloch DA et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. J Rheumatol 1988; 31: 315- 24
  9. Matthews DR, Hosker JP, Turner RC: Homeostasis Model Assesment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9
  10. Matsuda M, DeFronzo RA:Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 1999, 22: 1462-70
  11. Genuth S, Brownlee MA, Kuller LH, Samols E, Saudek CD, Sherwin R: Consensus development conference on insülin resistance. Diabetes Care 1998; 21(2): 310
  12. Festa A, D’Agostino R, Hales CN, Mykanen L, Haffner SM: Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subject. Diabetes Care 2000; 23: 624-8
  13. Haffner SM, Howard G, Mayer E, Bergman RN, Savage PJ, Rewers M, Mykanen L, Karter AJ, Hamman R, Saad MF: Insulin sensitivity and acute insulin response in Africans- Americans, Non-Hispanic Whites, and Hispanics with NIDDM: The Insulin Resistance Atherosclerosis Study. Diabetes 1997; 46: 63-9
  14. Svenson H: Insulin and atheroma 20 yrs perspective. Diabetes Care 1990; 13(6): 631-54
  15. Tanaka T, Itoh H, Doi K, Fukunaga Y, Hosoda K, Shintani M, Yamashita J, Chun TH, Inoue M, Masatsugu